Sofinnova Investments as of Dec. 31, 2020
Portfolio Holdings for Sofinnova Investments
Sofinnova Investments holds 66 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Natera Comm (NTRA) | 18.4 | $309M | 3.1M | 99.52 | |
| Karuna Therapeutics Comm | 11.8 | $198M | 2.0M | 101.59 | |
| Ascendis Pharma A/S Adr (ASND) | 11.0 | $185M | 1.1M | 166.78 | |
| Y-mAbs Therapeutics Comm | 6.5 | $109M | 2.2M | 49.51 | |
| United Therapeutics Corp Comm (UTHR) | 3.1 | $53M | 348k | 151.79 | |
| Checkmate Pharmaceuticals Comm | 3.1 | $53M | 3.6M | 14.59 | |
| AstraZeneca Adr (AZN) | 2.5 | $42M | 843k | 49.99 | |
| Inozyme Pharma Comm (INZY) | 2.5 | $42M | 2.0M | 20.64 | |
| Amgen Comm (AMGN) | 2.3 | $38M | 165k | 229.92 | |
| Jazz Pharmaceuticals Comm (JAZZ) | 2.1 | $35M | 213k | 165.05 | |
| Health Care Select Sector SPDR Comm Put Option (XLV) | 2.0 | $34M | 300k | 113.44 | |
| Galera Therapeutics Comm (GRTX) | 1.9 | $32M | 3.1M | 10.23 | |
| Abbvie Comm (ABBV) | 1.9 | $32M | 294k | 107.15 | |
| Akouos Adr | 1.8 | $30M | 1.5M | 19.83 | |
| Nextcure Comm | 1.7 | $29M | 2.7M | 10.90 | |
| Intra-Cellular Therapies Comm (ITCI) | 1.6 | $27M | 848k | 31.80 | |
| iShares Russell 2000 ETF Comm Put Option (IWM) | 1.5 | $26M | 130k | 196.06 | |
| Nucana Biomed Adr | 1.5 | $25M | 5.6M | 4.49 | |
| Merus Comm (MRUS) | 1.4 | $23M | 1.3M | 17.53 | |
| PTC Therapeutics Comm (PTCT) | 1.1 | $19M | 317k | 61.03 | |
| Reata Pharmaceuticals Comm | 1.1 | $18M | 149k | 123.62 | |
| Athira Pharma Comm (ATHA) | 1.0 | $17M | 509k | 34.25 | |
| Otonomy Comm | 1.0 | $17M | 2.6M | 6.47 | |
| Horizon Therapeutics Comm | 0.9 | $16M | 213k | 73.15 | |
| Protagonist Therapeutics Comm | 0.9 | $15M | 725k | 20.16 | |
| Biomarin Pharmaceutical Comm (BMRN) | 0.9 | $14M | 165k | 87.69 | |
| Aclaris Therapeutics Comm (ACRS) | 0.7 | $12M | 1.9M | 6.47 | |
| Regenxbio Comm (RGNX) | 0.7 | $12M | 271k | 45.36 | |
| GW Pharmaceuticals Adr | 0.7 | $12M | 101k | 115.41 | |
| Nucana Biomed Ordinary Shares | 0.6 | $11M | 2.4M | 4.49 | |
| Cytokinetics Comm (CYTK) | 0.6 | $11M | 508k | 20.78 | |
| MacroGenics Comm (MGNX) | 0.6 | $11M | 459k | 22.86 | |
| TCR2 Therapeutics Comm | 0.6 | $10M | 334k | 30.93 | |
| Insmed Comm (INSM) | 0.6 | $10M | 310k | 33.29 | |
| ObsEva SA Comm | 0.6 | $9.9M | 4.7M | 2.08 | |
| Arena Pharmaceuticals Comm | 0.6 | $9.3M | 121k | 76.83 | |
| Sarepta Therapeutics Comm (SRPT) | 0.5 | $8.8M | 52k | 170.50 | |
| ACADIA Pharmaceuticals Comm (ACAD) | 0.5 | $8.8M | 165k | 53.46 | |
| BioCryst Pharmaceuticals Comm (BCRX) | 0.5 | $8.4M | 1.1M | 7.45 | |
| Syndax Pharmaceuticals Comm (SNDX) | 0.5 | $8.3M | 373k | 22.24 | |
| Mirum Pharmaceuticals Comm (MIRM) | 0.5 | $7.9M | 455k | 17.46 | |
| Coherus BioSciences Comm (CHRS) | 0.4 | $7.6M | 435k | 17.38 | |
| ChemoCentryx Comm | 0.4 | $7.0M | 113k | 61.92 | |
| Jounce Therapeutics Comm | 0.4 | $6.5M | 925k | 7.00 | |
| Puma Biotechnology Comm (PBYI) | 0.4 | $6.5M | 630k | 10.26 | |
| Eli Lilly and Comm (LLY) | 0.4 | $6.2M | 37k | 168.85 | |
| Amarin Corp Adr | 0.3 | $5.7M | 1.2M | 4.89 | |
| Aligos Therapeutics Comm | 0.3 | $5.3M | 191k | 27.65 | |
| Calithera Biosciences Comm | 0.3 | $5.3M | 1.1M | 4.91 | |
| Arcus Biosciences Comm (RCUS) | 0.3 | $4.8M | 186k | 25.96 | |
| Acceleron Pharma Comm | 0.3 | $4.7M | 37k | 127.94 | |
| Iovance Biotherapeutics Comm Put Option (IOVA) | 0.3 | $4.6M | 100k | 46.40 | |
| Aptose Biosciences Comm | 0.3 | $4.3M | 981k | 4.38 | |
| IGM Biosciences Comm (IGMS) | 0.2 | $4.0M | 45k | 88.30 | |
| Kura Oncology Comm (KURA) | 0.2 | $3.9M | 121k | 32.66 | |
| TG Therapeutics Comm (TGTX) | 0.2 | $3.4M | 66k | 52.02 | |
| Marinus Pharmaceuticals Comm | 0.2 | $3.3M | 274k | 12.20 | |
| Immatics NV Comm (IMTX) | 0.2 | $3.0M | 280k | 10.79 | |
| Zogenix Comm | 0.1 | $1.8M | 90k | 19.99 | |
| Synlogic Comm | 0.1 | $1.2M | 575k | 2.16 | |
| Fate Therapeutics Comm (FATE) | 0.1 | $1.2M | 14k | 90.91 | |
| Kadmon Holdings Comm | 0.1 | $950k | 229k | 4.15 | |
| Replimune Group Comm (REPL) | 0.0 | $763k | 20k | 38.15 | |
| Liquidia Corp Comm (LQDA) | 0.0 | $436k | 148k | 2.95 | |
| PDS Biotechnology Corporation Comm (PDSB) | 0.0 | $305k | 143k | 2.14 | |
| Bioatla Comm (BCAB) | 0.0 | $102k | 3.0k | 34.00 |